Echocardiogram	O
demonstrated	O
severe	O
mitral	B-Disease
regurgitation	I-Disease
.	O

Morphine	B-Chemical
is	O
essential	O
for	O
severe	O
cancer	B-Disease
pain	O
management	O
.	O

Lisinopril	B-Chemical
effectively	O
lowers	O
blood	O
pressure	O
in	O
hypertension	B-Disease
.	O

Blood	O
cultures	O
grew	O
Staphylococcus	O
aureus	O
bacteremia	B-Disease
.	O

Rheumatoid	B-Disease
arthritis	I-Disease
causes	O
joint	O
inflammation	B-Disease
and	O
destruction	O
.	O

Cisplatin	B-Chemical
chemotherapy	O
often	O
results	O
in	O
nephrotoxicity	B-Disease
.	O

Benzodiazepines	B-Chemical
enhance	O
GABA	B-Chemical
receptor	O
activity	O
in	O
anxiety	B-Disease
.	O

Antipsychotics	O
block	O
dopamine	B-Chemical
D2	O
receptors	O
in	O
schizophrenia	B-Disease
.	O

Interferon	B-Chemical
beta	I-Chemical
reduces	O
relapse	O
rates	O
in	O
multiple	B-Disease
sclerosis	I-Disease
.	O

Heparin	B-Chemical
prevents	O
thrombosis	B-Disease
in	O
hospitalized	O
patients	O
.	O

Dopamine	B-Chemical
agonists	O
are	O
used	O
in	O
early	O
Parkinson	B-Disease
disease	I-Disease
.	O

Epinephrine	B-Chemical
is	O
the	O
first-line	O
treatment	O
for	O
anaphylaxis	B-Disease
.	O

Chronic	B-Disease
obstructive	I-Disease
pulmonary	I-Disease
disease	I-Disease
impairs	O
breathing	O
function	O
.	O

Heart	B-Disease
failure	I-Disease
results	O
in	O
fluid	O
retention	O
and	O
dyspnea	B-Disease
.	O

Atorvastatin	B-Chemical
reduces	O
cholesterol	B-Chemical
levels	O
and	O
cardiovascular	O
risk	O
.	O

Nitroglycerin	B-Chemical
provides	O
rapid	O
relief	O
in	O
angina	B-Disease
pectoris	I-Disease
.	O

Omeprazole	B-Chemical
treats	O
gastroesophageal	B-Disease
reflux	I-Disease
disease	I-Disease
and	O
ulcers	B-Disease
.	O

Zinc	B-Chemical
lozenges	O
may	O
reduce	O
common	B-Disease
cold	I-Disease
duration	O
slightly	O
.	O

Activated	O
charcoal	B-Chemical
absorbs	O
toxins	O
in	O
poisoning	O
cases	O
.	O

Combination	O
therapy	O
with	O
aspirin	B-Chemical
and	O
clopidogrel	B-Chemical
prevents	O
stroke	B-Disease
recurrence	O
.	O

Immunosuppression	O
with	O
tacrolimus	B-Chemical
and	O
mycophenolate	B-Chemical
prevents	O
transplant	O
rejection	O
.	O

TNF	B-Chemical
inhibitors	O
revolutionized	O
rheumatoid	B-Disease
arthritis	I-Disease
treatment	O
.	O

ACE	O
inhibitors	O
block	O
angiotensin	B-Chemical
converting	O
enzyme	O
activity	O
.	O

Thyroid	B-Chemical
hormone	I-Chemical
replacement	O
treats	O
hypothyroidism	B-Disease
effectively	O
.	O

Aspirin	B-Chemical
is	O
commonly	O
used	O
to	O
treat	O
headaches	B-Disease
and	O
reduce	O
fever	B-Disease
.	O

Penicillin	B-Chemical
allergies	O
can	O
trigger	O
anaphylaxis	B-Disease
in	O
sensitive	O
patients	O
.	O

MRI	O
revealed	O
multiple	O
brain	O
lesions	O
consistent	O
with	O
stroke	B-Disease
.	O

Systemic	B-Disease
lupus	I-Disease
erythematosus	I-Disease
is	O
an	O
autoimmune	O
condition	O
.	O

Serotonin	B-Chemical
reuptake	O
inhibitors	O
increase	O
synaptic	O
serotonin	O
.	O

Lithium	B-Chemical
toxicity	O
presents	O
with	O
tremor	B-Disease
and	O
confusion	B-Disease
.	O

Cancer	B-Disease
immunotherapy	O
uses	O
pembrolizumab	B-Chemical
and	O
nivolumab	B-Chemical
checkpoint	O
inhibitors	O
.	O

NSAIDs	B-Chemical
inhibit	O
cyclooxygenase	B-Chemical
reducing	O
prostaglandin	B-Chemical
synthesis	O
.	O

Biopsy	O
confirmed	O
adenocarcinoma	B-Disease
of	O
the	O
lung	O
tissue	O
.	O

Calcium	B-Chemical
channel	O
blockers	O
prevent	O
calcium	O
influx	O
in	O
cardiac	O
cells	O
.	O

Levodopa	B-Chemical
remains	O
the	O
gold	O
standard	O
for	O
Parkinson	B-Disease
disease	I-Disease
.	O

Albuterol	B-Chemical
inhalers	O
quickly	O
relieve	O
acute	O
asthma	B-Disease
symptoms	O
.	O

CT	O
scan	O
identified	O
acute	O
appendicitis	B-Disease
requiring	O
surgery	O
.	O

Combination	O
inhaler	O
contains	O
fluticasone	B-Chemical
and	O
salmeterol	B-Chemical
for	O
asthma	B-Disease
.	O

Laboratory	O
tests	O
revealed	O
hypoglycemia	B-Disease
and	O
ketoacidosis	B-Disease
.	O

Folic	B-Chemical
acid	I-Chemical
supplementation	O
prevents	O
neural	B-Disease
tube	I-Disease
defects	I-Disease
.	O

Alzheimer	B-Disease
disease	I-Disease
causes	O
progressive	O
memory	B-Disease
loss	I-Disease
and	O
dementia	B-Disease
.	O

Prolonged	O
corticosteroid	B-Chemical
use	O
leads	O
to	O
osteoporosis	B-Disease
risk	O
.	O

Opioid	B-Chemical
medications	O
carry	O
significant	O
addiction	B-Disease
risk	O
.	O

Statins	B-Chemical
may	O
cause	O
muscle	O
pain	O
known	O
as	O
myopathy	B-Disease
.	O

Amphotericin	B-Chemical
B	I-Chemical
is	O
associated	O
with	O
infusion-related	O
reactions	O
.	O

Chest	O
X-ray	O
confirmed	O
bilateral	O
pneumonia	B-Disease
infiltrates	O
.	O

The	O
patient	O
presented	O
with	O
fever	B-Disease
and	O
elevated	O
white	O
blood	O
cells	O
.	O

Naloxone	B-Chemical
rapidly	O
reverses	O
opioid	O
overdose	B-Disease
effects	O
.	O

Vitamin	B-Chemical
D	I-Chemical
supplementation	O
prevents	O
rickets	B-Disease
in	O
children	O
.	O

Sepsis	B-Disease
management	O
includes	O
antibiotics	B-Chemical
fluids	O
and	O
vasopressors	B-Chemical
.	O

Potassium	B-Chemical
chloride	I-Chemical
corrects	O
hypokalemia	B-Disease
in	O
hospitalized	O
patients	O
.	O

Iron	B-Chemical
deficiency	O
leads	O
to	O
microcytic	O
anemia	B-Disease
symptoms	O
.	O

Migraine	B-Disease
headaches	B-Disease
are	O
often	O
preceded	O
by	O
visual	O
aura	O
.	O

Beta	O
blockers	O
reduce	O
heart	O
rate	O
by	O
blocking	O
catecholamine	B-Chemical
effects	O
.	O

